FindTrial
Sign In

accordingly, each patient will receive 4 units of regular subcutaneous insulin injection for every 40.

2 trials

Sponsors

Mashhad University of Medical Sciences

Conditions

Condition 1: Type II diabetic. Condition 2: Cardiovascular disease. Type 2 diabetes mellitus Chronic ischaemic heart diseasetype II diabetic. Type 2 diabetes mellitus

Phase 3

Effect of glargine insulin on hyperglycemic control in type II diabetic patients
Active, not recruitingIRCT20130428013159N11
Mashhad University of Medical Sciencestype II diabetic. Type 2 diabetes mellitus
Start: 2020-04-03Target: 80Updated: 2020-03-24
Effect of glargine insulin on hyperglycemic control in type II diabetic patients
Active, not recruitingIRCT20130428013159N12
Mashhad University of Medical SciencesCondition 1: Type II diabetic. Condition 2: Cardiovascular disease. Type 2 diabetes mellitus Chronic ischaemic heart disease
Start: 2020-08-22Target: 80Updated: 2020-08-17